---
layout: post
title: "Schedules of Controlled Substances: Extension of Temporary Placement of Butonitazene, Flunitazene, and Metodesnitazene in Schedule I of the Controlled Substances Act"
date: 2026-02-05 19:09:05 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2024-07689
original_published: 2024-04-11 00:00:00 +0000
significance: 8.00
---

# Schedules of Controlled Substances: Extension of Temporary Placement of Butonitazene, Flunitazene, and Metodesnitazene in Schedule I of the Controlled Substances Act

**Published:** February 05, 2026 19:09 UTC
**Source:** Federal Register
**Original Published:** April 11, 2024 00:00 UTC
**Document Number:** 2024-07689

## Summary

The Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to extend the temporary schedule I status of butonitazene, flunitazene, and metodesnitazene, as identified in this order. The schedule I status of these three substances currently is in effect through April 12, 2024. This temporary order will extend the temporary scheduling of these three substances for one year, or until the permanent scheduling action for these substances is completed, whichever occurs first.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2024/04/11/2024-07689/schedules-of-controlled-substances-extension-of-temporary-placement-of-butonitazene-flunitazene-and)
- API: https://www.federalregister.gov/api/v1/documents/2024-07689

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
